Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Adma Biologics (ADMA) Other Non-Current Assets (2017 - 2025)

Adma Biologics (ADMA) has disclosed Other Non-Current Assets for 13 consecutive years, with $8.6 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets rose 52.02% year-over-year to $8.6 million, compared with a TTM value of $8.6 million through Dec 2025, up 52.02%, and an annual FY2025 reading of $8.6 million, up 52.02% over the prior year.
  • Other Non-Current Assets was $8.6 million for Q4 2025 at Adma Biologics, down from $8.8 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $9.1 million in Q2 2025 and bottomed at $2.2 million in Q1 2021.
  • Average Other Non-Current Assets over 5 years is $5.4 million, with a median of $5.0 million recorded in 2022.
  • Peak annual rise in Other Non-Current Assets hit 93.04% in 2021, while the deepest fall reached 35.85% in 2021.
  • Year by year, Other Non-Current Assets stood at $4.1 million in 2021, then rose by 17.27% to $4.8 million in 2022, then dropped by 2.1% to $4.7 million in 2023, then increased by 21.13% to $5.7 million in 2024, then skyrocketed by 52.02% to $8.6 million in 2025.
  • Business Quant data shows Other Non-Current Assets for ADMA at $8.6 million in Q4 2025, $8.8 million in Q3 2025, and $9.1 million in Q2 2025.